Aspiring, NSAIDs, and Acetaminophen Flashcards
function of NSAIDs
inhibit COX-1 and COX-2
how does aspirin inhibit function of COX-1 and COX-2
it covalently modifies the enzyme
how does NSAIDs inhibit COX-1 and COX-2
competes for the active site of cyclooxygenase (competitive inhibitor)
how does Acetaminophen inhibit COX-1 and COX-2
- interfers with the oxidative state of cyclooxygenase site
- inhibition impaired by “peroxide tone”
acetaminophen metabolites can form a conjugation with arachidonate acid in the brain to yield
a neuroactive metabolite
-or inhibition of the nitric oxide pathway mediated by a variety of neurotransmitter receptors including N-methyl-D-aspartate and substance P
general properties of NSAIDs
- anti-inflammatory
- analgesia (inability to feel pain)
- antipyresis
- gastric erosion
- cause renal dysfunction, impair renal function
- variable effect on platelet aggregation; increase cardiovascular pathologic events due to COX-2 inhibition
side effects of NSAID therapy
- gastric and intestinal ulceration
- anemia from resultant blood loss
- local irritation from drugs (organic acids) plus removal of PGE2 and PGI2 cytoprotective effects (less mucous covering GI)
how should patients at risk of GI toxicity be managed
-given celecoxib or other NSAID co-administered with a proton pump inhibitor or the PGE1 analong misoprostol
All NSAIDs have what effect on the cardiovascular system
- prothrombotic effects that increase risk of stroke, TIA, symptomatic coronary artery disease
- symptomatic peripheral vascular disease (COX-2 inhibition)
All NSAIDs can exacerbate
hypertension
what is the safest NSAIDs
naproxen bc it has the lowest cardiovascular toxicity effects
what are the adverse effects of NSAIDs on the renal system
- decrease renal blood flow and GFR in patients with congestive heart failure, liver disease (ascites); chronic renal disease; or those who are hypovolemic or dehydrated
- promote salt and water retention by producing PG-induced inhibition of both the reabsorption of chloride and the action of ADH
- may cause increased intravascular volume/edema
- analgesic nephropathy
- idiosyncratic and dose-related hepatic injury
symptoms of aspirin “intolerance”
-vasomotor rhinitis, generalized urticaria (hives), and bronchospasm, laryngeal edema and bronchoconstriction, flushing, hypotension and shock
aspirin “intolerance” occurs in pts with
- nasal polyps, asthma, and chronic urticaria
- asthma may be induced or exacerbated in such patients
what is the mechanism of aspirin intolerance
- defect in mast cell histamine storage/shunting or arachidonic acid to lipoxygenase pathway
- nonimmunologic mechanism
effects of aspirin in pregnancy
- prolong labor
- promote premature closure of ductus arteriosus
common drug interactions of NSAIDs
- prolong bleeding time (warfarin; heparin)
- increase the ulcerogenic effects of glucocorticoids
- reduce effects of diuretics and other antihypertensive agents
- reduce lithium clearance; also methotrexate; cyclosporine; aminoglycosides
therapeutic uses of NSAID
- relief pain and inflammation
- reduce body temp in febrile states
- closure of ductus arterioles
- with antihistamines, in pts with systemic mastocytosis
- adjunct in cancer-related hypercalcemia
- Bartter’s syndrome
- moderate cutaneous rxns in pts receiving niacin
aspirin in a — dependent pharmacokinetics
dose
MAO of aspirin
acetylates COX
what type of inhibitor is aspirin (salicylic acid)
competitive inhibitor
dose-dependent therapeutic effects of aspirin
- anti-platelet effects
- analgesia; reduction in febrile responses
- anti-inflammatory
aspirin metabolism
- aspirin is metabolized in plasam to yield salicylic acid
- salicylic acid is biotransformed in liver and mitochondria
therapeutic uses of aspirin
-antipyretic, analgesic, anti-inflammatory